99.4%
NeuroblastomaguadecitabineNational Cancer InstituteaCD40aGD2entinostat
…Background Neuroblastoma is the second most common solid pediatric tumor, with ~50% of p…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 47 of 2459atorvastatinhypercholesterolemia
… promoted tumour growth, with significant tumour restriction on atorvastatin pre-exposure. CCR7 low, CD40low, CD80 low, CD86 lowPDL1high FAS…
TarlatamabVIB193CatumaxomabLUSCPAADLUADTebentafuspCHOLKIRCsolid tumors+1 more
…itional drugs: the TCR-based Tebentafusp and the antibody-based Tarlatamab. The limited progress in this field is largely attributed to ch…
pancreatic cancerADoBindADoBind-MMAEADoBind-DM1MC001
…otoxicity with potent immunotherapeutic properties for treating pancreatic cancer, enabling a multipronged, potentially safer treatment for a bro…
Visual Analogue ScalePrednisolonePulmonary SarcoidosisMethotrexateMTXHydroxychloroquine
…th greater improvements in KSQ domains and a smaller decline in Visual Analogue Scale.Abstract P21 Figure 1Change in King’s Sarcoidosis Questionnaire…
asthmaglycopyrroniumbeclometasoneCOPDformoterolBDP/FF/GNCT04902573
… the full analysis set. Patients are adults with a diagnosis of asthma, able to consent, with/without concomitant COPD. Before enrolme…
sarcoidosisOSA
…sion OSA is under-diagnosed in sarcoidosis. Active screening of sarcoidosis patients for OSA in ILD clinic is feasible utilizing ESS and ST…
fILDconnective tissue diseasediabetesliver diseaseheart diseasefibrotic interstitial lung diseasecoronary artery disease
…nterstitial lung disease), IPF (idiopathic pulmonary fibrosis), fILD (fibrotic interstitial lung disease), UIP (usual interstitial p…
asthmaasthma-relatedGORDOmalizumab
…healthy controls Characteristics Healthy controls Mild/moderate asthma Severe asthma Female Male p-value* Female Male p-value# Female …
World Health OrganizationpolioBill and Melinda Gates FoundationBMGFWHOnon-communicable diseases
…ction The Bill and Melinda Gates Foundation (BMGF) has been the World Health Organization’s (WHO) second biggest source of funding in recent years, contr…
haemochromatosiscirrhosishepatocellular carcinomaHCCviral hepatitis
… to case note review, 82/123 (66.7%) patients transplanted with haemochromatosis had additional aetiological risk factors for cirrhosis, includi…
Seladelparseladelpar-treatedcirrhosisprimary biliary cholangitisPBC
…Seladelpar is a first-in-class delpar (selective PPAR-delta agonist) indic…